Cargando…

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which h...

Descripción completa

Detalles Bibliográficos
Autores principales: Leighton, Danielle J., Ansari, Morad, Newton, Judith, Parry, David, Cleary, Elaine, Colville, Shuna, Stephenson, Laura, Larraz, Juan, Johnson, Micheala, Beswick, Emily, Wong, Michael, Gregory, Jenna, Carod Artal, Javier, Davenport, Richard, Duncan, Callum, Morrison, Ian, Smith, Colin, Swingler, Robert, Deary, Ian J., Porteous, Mary, Aitman, Timothy J., Chandran, Siddharthan, Gorrie, George H., Pal, Suvankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971124/
https://www.ncbi.nlm.nih.gov/pubmed/36515702
http://dx.doi.org/10.1007/s00415-022-11505-0
_version_ 1784898043106033664
author Leighton, Danielle J.
Ansari, Morad
Newton, Judith
Parry, David
Cleary, Elaine
Colville, Shuna
Stephenson, Laura
Larraz, Juan
Johnson, Micheala
Beswick, Emily
Wong, Michael
Gregory, Jenna
Carod Artal, Javier
Davenport, Richard
Duncan, Callum
Morrison, Ian
Smith, Colin
Swingler, Robert
Deary, Ian J.
Porteous, Mary
Aitman, Timothy J.
Chandran, Siddharthan
Gorrie, George H.
Pal, Suvankar
author_facet Leighton, Danielle J.
Ansari, Morad
Newton, Judith
Parry, David
Cleary, Elaine
Colville, Shuna
Stephenson, Laura
Larraz, Juan
Johnson, Micheala
Beswick, Emily
Wong, Michael
Gregory, Jenna
Carod Artal, Javier
Davenport, Richard
Duncan, Callum
Morrison, Ian
Smith, Colin
Swingler, Robert
Deary, Ian J.
Porteous, Mary
Aitman, Timothy J.
Chandran, Siddharthan
Gorrie, George H.
Pal, Suvankar
author_sort Leighton, Danielle J.
collection PubMed
description BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which hosts the Scottish MND Register. Long survival was defined as > 8 years from diagnosis. 11 phenotypic variables were analysed. Whole genome sequencing (WGS) was performed and variants within 49 MND-associated genes examined. Each individual was screened for C9orf72 repeat expansions. Data from ancestry-matched Scottish populations (the Lothian Birth Cohorts) were used as controls. RESULTS: 58 long survivors were identified. Median survival from diagnosis was 15.5 years. Long survivors were significantly younger at onset and diagnosis than incident patients and had a significantly longer diagnostic delay. 42% had the MND subtype of primary lateral sclerosis (PLS). WGS was performed in 46 individuals: 14 (30.4%) had a potentially pathogenic variant. 4 carried the known SOD1 p.(Ile114Thr) variant. Significant variants in FIG4, hnRNPA2B1, SETX, SQSTM1, TAF15, and VAPB were detected. 2 individuals had a variant in the SPAST gene suggesting phenotypic overlap with hereditary spastic paraplegia (HSP). No long survivors had pathogenic C9orf72 repeat expansions. CONCLUSIONS: Long survivors are characterised by younger age at onset, increased prevalence of PLS and longer diagnostic delay. Genetic analysis in this cohort has improved our understanding of the phenotypes associated with the SOD1 variant p.(Ile114Thr). Our findings confirm that pathogenic expansion of C9orf72 is likely a poor prognostic marker. Genetic screening using targeted MND and/or HSP panels should be considered in those with long survival, or early-onset slowly progressive disease, to improve diagnostic accuracy and aid prognostication. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11505-0.
format Online
Article
Text
id pubmed-9971124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99711242023-03-01 Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland Leighton, Danielle J. Ansari, Morad Newton, Judith Parry, David Cleary, Elaine Colville, Shuna Stephenson, Laura Larraz, Juan Johnson, Micheala Beswick, Emily Wong, Michael Gregory, Jenna Carod Artal, Javier Davenport, Richard Duncan, Callum Morrison, Ian Smith, Colin Swingler, Robert Deary, Ian J. Porteous, Mary Aitman, Timothy J. Chandran, Siddharthan Gorrie, George H. Pal, Suvankar J Neurol Original Communication BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which hosts the Scottish MND Register. Long survival was defined as > 8 years from diagnosis. 11 phenotypic variables were analysed. Whole genome sequencing (WGS) was performed and variants within 49 MND-associated genes examined. Each individual was screened for C9orf72 repeat expansions. Data from ancestry-matched Scottish populations (the Lothian Birth Cohorts) were used as controls. RESULTS: 58 long survivors were identified. Median survival from diagnosis was 15.5 years. Long survivors were significantly younger at onset and diagnosis than incident patients and had a significantly longer diagnostic delay. 42% had the MND subtype of primary lateral sclerosis (PLS). WGS was performed in 46 individuals: 14 (30.4%) had a potentially pathogenic variant. 4 carried the known SOD1 p.(Ile114Thr) variant. Significant variants in FIG4, hnRNPA2B1, SETX, SQSTM1, TAF15, and VAPB were detected. 2 individuals had a variant in the SPAST gene suggesting phenotypic overlap with hereditary spastic paraplegia (HSP). No long survivors had pathogenic C9orf72 repeat expansions. CONCLUSIONS: Long survivors are characterised by younger age at onset, increased prevalence of PLS and longer diagnostic delay. Genetic analysis in this cohort has improved our understanding of the phenotypes associated with the SOD1 variant p.(Ile114Thr). Our findings confirm that pathogenic expansion of C9orf72 is likely a poor prognostic marker. Genetic screening using targeted MND and/or HSP panels should be considered in those with long survival, or early-onset slowly progressive disease, to improve diagnostic accuracy and aid prognostication. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11505-0. Springer Berlin Heidelberg 2022-12-14 2023 /pmc/articles/PMC9971124/ /pubmed/36515702 http://dx.doi.org/10.1007/s00415-022-11505-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Communication
Leighton, Danielle J.
Ansari, Morad
Newton, Judith
Parry, David
Cleary, Elaine
Colville, Shuna
Stephenson, Laura
Larraz, Juan
Johnson, Micheala
Beswick, Emily
Wong, Michael
Gregory, Jenna
Carod Artal, Javier
Davenport, Richard
Duncan, Callum
Morrison, Ian
Smith, Colin
Swingler, Robert
Deary, Ian J.
Porteous, Mary
Aitman, Timothy J.
Chandran, Siddharthan
Gorrie, George H.
Pal, Suvankar
Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title_full Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title_fullStr Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title_full_unstemmed Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title_short Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
title_sort genotype–phenotype characterisation of long survivors with motor neuron disease in scotland
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971124/
https://www.ncbi.nlm.nih.gov/pubmed/36515702
http://dx.doi.org/10.1007/s00415-022-11505-0
work_keys_str_mv AT leightondaniellej genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT ansarimorad genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT newtonjudith genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT parrydavid genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT clearyelaine genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT colvilleshuna genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT stephensonlaura genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT larrazjuan genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT johnsonmicheala genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT beswickemily genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT wongmichael genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT gregoryjenna genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT carodartaljavier genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT davenportrichard genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT duncancallum genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT morrisonian genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT smithcolin genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT swinglerrobert genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT dearyianj genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT porteousmary genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT aitmantimothyj genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT chandransiddharthan genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT gorriegeorgeh genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT palsuvankar genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland
AT genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland